Expertise in
9
conditions

Pierre Asfar

Angers, FR 
Expertise in
9
conditions
Angers, FR 
OverviewLocationsClinical Research

Overview

Pierre Asfar practices in Angers, France. Mr. Asfar is highly rated in 9 conditions, according to our data. His top areas of expertise are Sepsis, Low Blood Pressure, Hypothermia, and Pneumonia.

His clinical research consists of co-authoring 158 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

Angers, France
Other Locations
Nantes, 44000, France
Toulon, France
CHU d'Angers
France
30 Boulevard Jean Monnet, Paris, 44093, France
Nancy, France
INSERM CIC 1402, And CIC 1435, Point A-Pitre All In France, Montauban, France
2 Bis, Boulevard Tonnellé, Tours Cedex 09, Tours, 37044, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

Relation Between Mean Arterial Pressure and Renal Resistive Index in the Early Phase of Septic Shock
Relation Between Mean Arterial Pressure and Renal Resistive Index in the Early Phase of Septic Shock
Enrollment Status: Completed
Publish Date: October 01, 2025
Intervention Type: Device
Study Phase: Not Applicable
A Randomized, Double-blind, Placebo-controlled, Study Evaluating the Efficacy and Safety of Otilimab IV in Patients With Severe Pulmonary COVID-19 Related Disease
A Randomized, Double-blind, Placebo-controlled, Study Evaluating the Efficacy and Safety of Otilimab IV in Patients With Severe Pulmonary COVID-19 Related Disease
Enrollment Status: Completed
Publish Date: September 23, 2024
Intervention Type: Biological, Drug
Study Drugs: Otilimab, Standard of Care
Study Phase: Phase 2
Host Response Mediators in Coronavirus (COVID-19) Infection - Is There a Protective Effect of Losartan and Other ARBs on Outcomes of Coronavirus Infection?
Host Response Mediators in Coronavirus (COVID-19) Infection - Is There a Protective Effect of Losartan and Other ARBs on Outcomes of Coronavirus Infection?
Enrollment Status: Terminated
Publish Date: February 16, 2023
Intervention Type: Drug
Study Drug: Losartan
Study Phase: Phase 3
Percutaneous Temporary Placement of a Phrenic Nerve Stimulator for Diaphragm Pacing
Percutaneous Temporary Placement of a Phrenic Nerve Stimulator for Diaphragm Pacing
Enrollment Status: Completed
Publish Date: November 16, 2022
Intervention Type: Device
Study Phase: Not Applicable
Mucormycosis in ICU: A French Multicenter Cohort Study
Mucormycosis in ICU: A French Multicenter Cohort Study
Enrollment Status: Completed
Publish Date: November 08, 2022
Value of Early Treatment With Polyvalent Immunoglobulin in the Management of Acute Respiratory Distress Syndrome Associated With SARS-CoV-2 Infections
Value of Early Treatment With Polyvalent Immunoglobulin in the Management of Acute Respiratory Distress Syndrome Associated With SARS-CoV-2 Infections
Enrollment Status: Completed
Publish Date: August 19, 2021
Intervention Type: Drug
Study Drug: Human Immunoglobulin
Study Phase: Phase 3
CACOLAC : Randomized Trial of Citrulline Administration in the Hospital Patient in Intensive Care for COVID-19 Acute Respiratory Distress Syndrome
CACOLAC : Randomized Trial of Citrulline Administration in the Hospital Patient in Intensive Care for COVID-19 Acute Respiratory Distress Syndrome
Enrollment Status: Completed
Publish Date: June 02, 2021
Intervention Type: Other, Dietary supplement
Study Phase: Not Applicable
Therapeutic Hypothermia After Cardiac Arrest in Non Shockable Rhythm at Rescue Arrival: The HYPERION Study
Therapeutic Hypothermia After Cardiac Arrest in Non Shockable Rhythm at Rescue Arrival: The HYPERION Study
Enrollment Status: Completed
Publish Date: January 16, 2019
Intervention Type: Procedure
Study Phase: Not Applicable
View 7 Less Clinical Trials

158 Total Publications

Correction: Impact of non-invasive oxygen reserve index versus standard SpO2 monitoring on peripheral oxygen saturation during endotracheal intubation in the intensive care unit: Protocol for the randomized controlled trial NESOI2.
Correction: Impact of non-invasive oxygen reserve index versus standard SpO2 monitoring on peripheral oxygen saturation during endotracheal intubation in the intensive care unit: Protocol for the randomized controlled trial NESOI2.
Journal: PloS one
Published: July 02, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Asfar's expertise for a condition
ConditionClose
    View All 8 Advanced Conditions
    View All 15 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile